{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:45:48Z","timestamp":1753357548595,"version":"3.38.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10067-025-07327-w","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T19:39:20Z","timestamp":1737661160000},"page":"1237-1243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of increased serum I-309 with phenotypes, disease activity, and cytokine pattern in primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"44","author":[{"given":"Yan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-642X","authenticated-orcid":false,"given":"Zaixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"7327_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Solans R, Fraile G, Su\u00e1rez-Cuervo C, Casanovas A et al (2016) Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 75:348\u201355","journal-title":"Ann Rheum Dis"},{"key":"7327_CR2","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.20111627","volume":"210","author":"S Das","year":"2013","unstructured":"Das S, Sarrou E, Podgrabinska S, Cassella M, Mungamuri SK, Feirt N et al (2013) Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med 210:1509\u20131528","journal-title":"J Exp Med"},{"key":"7327_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/01.CIR.102.7.786","volume":"102","author":"NS Haque","year":"2000","unstructured":"Haque NS, Zhang X, French DL, Li J, Poon M, Fallon JT et al (2000) CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 102:786\u2013792","journal-title":"Circulation"},{"key":"7327_CR4","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.immuni.2021.06.008","volume":"54","author":"SS Liu","year":"2021","unstructured":"Liu SS, Liu C, Lv XX, Cui B, Yan J, Li YX et al (2021) The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis. Immunity 54:2042\u20132056.e8","journal-title":"Immunity"},{"key":"7327_CR5","doi-asserted-by":"publisher","first-page":"110343","DOI":"10.1016\/j.intimp.2023.110343","volume":"120","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang Z, Wang Y, Zhang Y, Min J, Li X et al (2023) The chemokine CCL1 facilitates pulmonary fibrosis by promoting macrophage migration and M2 polarization. Int Immunopharmacol 120","journal-title":"Int Immunopharmacol"},{"key":"7327_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610\u2013621","journal-title":"N Engl J Med"},{"key":"7327_CR7","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20182111","volume":"216","author":"L Knipfer","year":"2019","unstructured":"Knipfer L, Schulz-Kuhnt A, Kindermann M (2019) A CCL1\/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation. J Exp Med 216:2763\u201377","journal-title":"J Exp Med"},{"key":"7327_CR8","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.174.8.5082","volume":"174","author":"M Gombert","year":"2005","unstructured":"Gombert M, Dieu-Nosjean MC, Winterberg F, B\u00fcnemann E, Kubitza RC, Da Cunha L et al (2005) CCL1-CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol (Baltimore, Md\u202f: 1950) 174:5082\u201391","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"179","key":"7327_CR9","first-page":"1740","volume":"2007","author":"JA Gonzalo","year":"1950","unstructured":"Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA et al (1950) Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1: CCR1 axis. J Immunol (Baltimore, Md) 2007(179):1740\u20131750","journal-title":"J Immunol (Baltimore, Md)"},{"key":"7327_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yjmcc.2019.05.009","volume":"132","author":"M Vila-Caballer","year":"2019","unstructured":"Vila-Caballer M, Gonz\u00e1lez-Granado JM, Zorita V, Abu Nabah YN, Silvestre-Roig C, Del Monte-Monge A et al (2019) Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice. J Mol Cell Cardiol 132:154\u2013163","journal-title":"J Mol Cell Cardiol"},{"key":"7327_CR11","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.4049\/jimmunol.179.9.5760","volume":"179","author":"J Cantor","year":"2007","unstructured":"Cantor J, Haskins K (2007) Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR1 and CCL1. J Immunol (Baltimore, Md\u202f: 1950) 179:5760\u20137","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"7327_CR12","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1093\/rheumatology\/keab098","volume":"60","author":"MP Gomez Hernandez","year":"2021","unstructured":"Gomez Hernandez MP, Starman EE, Davis AB, Withanage MHH, Zeng E, Lieberman SM et al (2021) A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford, England) 60:4765\u201377","journal-title":"Rheumatology (Oxford, England)"},{"key":"7327_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"7327_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG (2016) Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75:382\u2013389","journal-title":"Ann Rheum Dis"},{"key":"7327_CR15","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S2665-9913(23)00340-5","volume":"6","author":"Y Nguyen","year":"2024","unstructured":"Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F et al (2024) Identification of distinct subgroups of Sj\u00f6gren\u2019s disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts. The Lancet Rheumatology 6:e216\u2013e225","journal-title":"The Lancet Rheumatology"},{"issue":"Suppl 112","key":"7327_CR16","first-page":"210","volume":"36","author":"A Alunno","year":"2018","unstructured":"Alunno A, Bartoloni E, Valentini V, La Paglia GMC, Valentini E, Leone MC et al (2018) Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 36(Suppl 112):210\u2013214","journal-title":"Clin Exp Rheumatol"},{"key":"7327_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nri3843","volume":"15","author":"SS Evans","year":"2015","unstructured":"Evans SS, Repasky EA, Fisher DT (2015) Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol 15:335\u2013349","journal-title":"Nat Rev Immunol"},{"key":"7327_CR18","doi-asserted-by":"publisher","first-page":"106878","DOI":"10.1016\/j.intimp.2020.106878","volume":"88","author":"C Chen","year":"2020","unstructured":"Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z (2020) Relationships between increased circulating YKL-40, IL-6 and TNF-\u03b1 levels and phenotypes and disease activity of primary Sj\u00f6gren\u2019s syndrome. Int Immunopharmacol 88","journal-title":"Int Immunopharmacol"},{"key":"7327_CR19","first-page":"726","volume":"31","author":"T Mandl","year":"2004","unstructured":"Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G (2004) CD4+ T-lymphocytopenia\u2013a frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 31:726\u2013728","journal-title":"J Rheumatol"},{"key":"7327_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","volume":"137","author":"M Mingueneau","year":"2016","unstructured":"Mingueneau M, Boudaoud S, Haskett S, Reynolds TL, Nocturne G, Norton E et al (2016) Cytometry by time-of-flight immunophenotyping identifies a blood Sj\u00f6gren\u2019s signature correlating with disease activity and glandular inflammation. J Allergy Clin Immunol 137:1809\u201321.e12","journal-title":"J Allergy Clin Immunol"},{"key":"7327_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1189\/jlb.0212107","volume":"92","author":"A Asai","year":"2012","unstructured":"Asai A, Nakamura K, Kobayashi M, Herndon DN, Suzuki F (2012) CCL1 released from M2b macrophages is essentially required for the maintenance of their properties. J Leukoc Biol 92:859\u2013867","journal-title":"J Leukoc Biol"},{"key":"7327_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1189\/jlb.1005586","volume":"80","author":"M Sironi","year":"2006","unstructured":"Sironi M, Martinez FO, D\u2019Ambrosio D, Gattorno M, Polentarutti N, Locati M et al (2006) Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 80:342\u2013349","journal-title":"J Leukoc Biol"},{"key":"7327_CR23","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1038\/sj.onc.1207903","volume":"23","author":"G Tamg\u00fcney","year":"2004","unstructured":"Tamg\u00fcney G, Van Snick J, Fickenscher H (2004) Autocrine stimulation of rhadinovirus-transformed T cells by the chemokine CCL1\/I-309. Oncogene 23:8475\u20138485","journal-title":"Oncogene"},{"key":"7327_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1183\/09031936.06.00134304","volume":"28","author":"R Montes-Vizuet","year":"2006","unstructured":"Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, Negrete-Garc\u00eda MC, Vel\u00e1squez JR, Teran LM (2006) CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J 28:59\u201367","journal-title":"Eur Respir J"},{"key":"7327_CR25","doi-asserted-by":"publisher","first-page":"e13680","DOI":"10.1111\/myc.13680","volume":"67","author":"Y Luo","year":"2024","unstructured":"Luo Y, Tang JF, Gao FF, Quan JH, Ma CT, Li SJ et al (2024) NLRP3 regulates CIITA\/MHC II axis and interferon-\u03b3-inducible chemokines in Malassezia globosa-infected keratinocytes. Mycoses 67:e13680","journal-title":"Mycoses"},{"key":"7327_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/bjophthalmol-2017-311079","volume":"102","author":"R Chang","year":"2018","unstructured":"Chang R, Yi S, Tan X, Huang Y, Wang Q, Su G et al (2018) MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 102:282\u2013290","journal-title":"Br J Ophthalmol"},{"key":"7327_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","volume":"17","author":"K Psianou","year":"2018","unstructured":"Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI et al (2018) Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 17:1053\u20131064","journal-title":"Autoimmun Rev"},{"key":"7327_CR28","doi-asserted-by":"crossref","unstructured":"Yang J, Su J (2022) The role of Th9 CD4(+) T cells and IL-9 during primary Sjogren\u2019s syndrome. J Clin Lab Anal 36","DOI":"10.1002\/jcla.24646"},{"key":"7327_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41598-022-19397-w","volume":"12","author":"N Kaneko","year":"2022","unstructured":"Kaneko N, Chen H, Perugino CA, Maehara T, Munemura R, Yokomizo S et al (2022) Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sj\u00f6gren\u2019s syndrome. Sci Rep 12:12","journal-title":"Sci Rep"},{"key":"7327_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med 378:931\u2013939","journal-title":"N Engl J Med"},{"key":"7327_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/mr\/road010","volume":"34","author":"H Zhong","year":"2023","unstructured":"Zhong H, Wang Y, Yang P, Duan X, Wang Y, Xu J et al (2023) Hyperglobulinemia predicts increased risk of mortality in primary Sj\u00f6gren\u2019s syndrome: Based on a Chinese multicentre registry. Modern Rheumatol 34:137\u2013143","journal-title":"Modern Rheumatol"},{"key":"7327_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/imm.12524","volume":"146","author":"EJ Swindle","year":"2015","unstructured":"Swindle EJ, Brown JM, R\u00e5dinger M, DeLeo FR, Metcalfe DD (2015) Interferon-\u03b3 enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus. Immunology 146:470\u2013485","journal-title":"Immunology"},{"issue":"181","key":"7327_CR33","first-page":"8576","volume":"2008","author":"CJ Henry","year":"1950","unstructured":"Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM (1950) IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol (Baltimore, Md 2008(181):8576\u20138584","journal-title":"J Immunol (Baltimore, Md"},{"key":"7327_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/archneurol.2009.138","volume":"66","author":"S Cepok","year":"2009","unstructured":"Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G et al (2009) Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. Arch Neurol 66:1216\u20131223","journal-title":"Arch Neurol"},{"key":"7327_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M et al (2015) Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J Autoimmun 63:47\u201358","journal-title":"J Autoimmun"},{"key":"7327_CR36","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall JC, Baer AN, Shah AA, Criswell LA, Shiboski CH, Rosen A et al (2015) Molecular subsetting of Interferon pathways in Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol (Hoboken, NJ) 67:2437\u20132446","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"7327_CR37","doi-asserted-by":"publisher","first-page":"108758","DOI":"10.1016\/j.intimp.2022.108758","volume":"108","author":"Y Liang","year":"2022","unstructured":"Liang Y, Zhang Z, Li J, Luo W, Jiang T, Yang Z (2022) Association between IL-7 and primary Sj\u00f6gren\u2019s syndrome: a single-center study and a systematic scoping review. Int Immunopharmacol 108","journal-title":"Int Immunopharmacol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07327-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:21:07Z","timestamp":1740558067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07327-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7327"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07327-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosures None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}